Alalwan A

February 16, 2022
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Summary Background Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given current trends. Methods This analysis […]

Read More
September 26, 2020
A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia
Summary Background No virologic cure exists for hepatitis B virus (HBV) infection, and existing therapies are designed to control viral replication. We aimed to estimate the national prevalence of HBsAg in 2017 and study the impact of an enhanced diagnosis rate and universal treatment administration on HBV-related outcomes in Saudi Arabia. Materials and methods A […]

Read More

English